Employment and Support Allowance: Underpayments

Debate between Lord Walney and Sarah Newton

Monday 25th February 2019 Commons Chamber

[Sarah Newton]

I reassure the hon. Gentleman that people would have been on benefits, so it is not fair to say that—or to characterise the situation as one in which—people would not have had any benefits. Clearly, some people would have benefited from additional payments because we did not give them the right amount of money, but people did have those payments in the first place.

[John Woodcock (Barrow and Furness) (Ind)]

The Minister is sorry and says lessons are being learnt, but where is the sense of accountability for this terrible error, which has had such a profound effect on many thousands of people’s lives? Where are the extra staff and resource coming from to sort out this problem? Which areas of the DWP’s work are being deprioritised to make this right?

[Sarah Newton]

On the question about accountability, of course the National Audit Office has undertaken an inquiry into this issue and so has the Public Accounts Committee. There has been a lot of scrutiny, and it is quite right that there has been so much. I do not hold back from saying that this should never have happened. It is a very serious situation that we do take very seriously and are working hard to rectify. Please be assured that that is the case, that we have made the resources available, and that we will complete this exercise this year.

Social Security

Debate between Lord Walney and Sarah Newton

Wednesday 6th February 2019 Commons Chamber

[Sarah Newton]

These two statutory instruments will increase the value of lump sum awards payable under the Pneumoconiosis etc. (Workers’ Compensation) Act 1979 and the diffuse mesothelioma scheme, which was set up by the Child Maintenance and Other Payments Act 2008. Those schemes stand apart from the main social security benefits uprating procedure, and there is no legislative requirement to review the level of payments each year. None the less, I am happy to increase the amounts payable from 1 April this year by September’s consumer prices index of 2.4%.

The Government recognise the very great suffering of individuals and their families caused by the serious and often fatal diseases resulting from exposure to asbestos, coal dust and other forms of dust. The individuals affected may be unable to bring a successful claim for damages, often owing to the long latency period of their condition, but they can still claim compensation through these schemes.

I will briefly summarise the specific purpose of the two compensation schemes. The Pneumoconiosis etc. (Workers’ Compensation) Act 1979, which for simplicity I will refer to as the 1979 Act scheme, provides a lump sum compensation payment to those who have one of five dust-related respiratory diseases covered by the scheme, who are unable to claim damages from employers because they have gone out of business and who have not brought any action against others for damages. The five diseases covered by the 1979 Act scheme are diffuse mesothelioma, bilateral diffuse pleural thickening, pneumoconiosis and byssinosis, as well as primary carcinoma of the lung if accompanied by asbestosis or bilateral diffuse pleural thickening. The 2008 mesothelioma lump sum payment scheme widens the criteria for compensation to those who have contracted diffuse mesothelioma but who are unable to claim compensation for that disease under the 1979 Act scheme—for example, those people who were self-employed or whose exposure to asbestos was not due to work.

Payments under the 1979 Act scheme are based on the age of the person with the disease and their level of disablement at the time of their diagnosis. All payments for diffuse mesothelioma are made at the 100% rate. All payments under the 2008 scheme are also made at the 100% disablement rate and based on age, with the highest payments going to the youngest people with the disease. In the last full year, from April 2017 to March 2018, 3,680 people received payments under both schemes, totalling £49.2 million.

I am aware that the prevalence of diffuse mesothelioma is a particular concern of Members, given the number of deaths from this disease in Great Britain. It is at a historically high level. The life expectancy of those diagnosed with diffuse mesothelioma is poor, with many people dying within 12 months of diagnosis. The disease has a strong association with exposure to asbestos, and current evidence suggests that around 85% of all mesotheliomas diagnosed in men are attributable to asbestos exposures that occurred through work. Our latest available information suggests that there will continue to be around 2,500 diffuse mesothelioma deaths per year before the number of cases begins to fall during the next decade, reflecting a reduction in asbestos exposures after 1980.

[John Woodcock (Barrow and Furness) (Ind)]

The Minister will be aware that Barrow and Furness has the highest number of asbestos-related cancer deaths in the whole of England and Wales. Is she aware of how many sufferers who were previously compensated under the scheme covering pleural plaques are now falling victim to terminal asbestosis and finding themselves ineligible for any compensation under these schemes? Does she not feel that that is unjust? Will she meet me and representatives of my community to discuss that?

[Sarah Newton]

I am always happy to meet colleagues from across the House if they have particular constituency issues or if people who really need support are falling between the cracks. There are three different schemes available to support people, and we are talking about two of them today. I would be happy to meet the hon. Gentleman to explore those issues and to discuss the three compensation programmes to see whether there is more that we can do. We are absolutely committed to ensuring that people get the support to which they are entitled.

We expect to see a decline in the number of people being diagnosed with diffuse mesothelioma in the coming years, but many people will continue to develop the condition and the other respiratory diseases, based on their exposure, for some time to come. That is why the Government are committed to working in partnership with their arm’s length bodies and agencies to improve the lives of those with respiratory diseases. I want to give the House an example of that commitment.

Last summer, I hosted a lung health summit, bringing together the Union of Democratic Mineworkers, my hon. Friends the Members for Sherwood (Mark Spencer) and for Mansfield (Ben Bradley) and representatives from the British Lung Association and the NHS. This was an opportunity to discuss the important work that the Government and our partners are doing and to listen to the first-hand experiences and problems, brought to my attention by my hon. Friend the Member for Sherwood, that miners are encountering today as they try to get an appropriate diagnosis and therefore the financial support that we want them to receive.

A huge amount of work has been done as a result of that lung health summit, and I was delighted—as I hope everyone will be—to see that the recently published NHS long-term plan recognises the objective of improving outcomes for people with respiratory disease. The long-term plan sets out how the NHS will take action in a number of areas. This includes expanding programmes that support earlier diagnosis of respiratory diseases—including the pioneering lung health checks trialled in Manchester and Liverpool—and increasing access to proven treatments such as pulmonary rehabilitation. As part of the engagement process for the Government’s long-term plan, an NHS England respiratory oversight group has been created, which includes membership of the British Lung Foundation. In addition, NHS England has been working closely with the taskforce for lung health, which has also recently published its own five-year plan to improve lung health.

I want to take a few moments to talk about the work of the Health and Safety Executive in this regard. It does excellent work, the length and breadth of the country, but we seldom have an opportunity to reflect on that in this House. As a nation, we should be really proud of our long history of trying to prevent illness and injury at work. The very first factory inspectors were appointed under the Factory Act 1833 to prevent injury and overworking among child textile workers, and we have come a long way since then. The Health and Safety at Work etc. Act came into force in October 1974 and the Health and Safety Executive was formed in January 1975. The HSE is now well established as a mature regulator with a mission to prevent work-related death, injury and ill health. This is borne out by the most recent published HSE statistics, which show a long-term downward trend in the rate of self-reported non-fatal accidents and fatal accidents to workers. Indeed, the UK consistently has one of the lowest standardised rates of fatal injury when compared with any other large economy.

Turning back to the importance of these regulations, I am sure we all agree that, while no amount of money can ever compensate individuals or their families for the suffering and loss caused by the diffuse mesothelioma and pneumoconiosis covered by the 1979 Act scheme, those who have those diseases rightly deserve some form of monetary compensation. Finally, I am required to confirm to the House that these provisions are compatible with the European convention on human rights, and I am happy so to do.